Assyro AI

Orange Book product · Brand (NDA)

KARBINAL ER

CARBINOXAMINE MALEATE

Brand (NDA)NDA 022556RX AYTU

At a glance

Mar 28, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 28, 2013

    13 yr 5 mo ago

  2. Today

  3. Patent 9522191 expires

    Listed drug product patent expiration.

    Jun 15, 2027

    in 1 yr

  4. Patent 8062667 expires

    Listed drug product patent expiration.

    Mar 29, 2029

    in 2 yr 10 mo

Pharmaceutical detail

Active ingredient

CARBINOXAMINE MALEATE

Strength

4MG/5ML

Dosage form

SUSPENSION, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 022556

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9522191Jun 15, 2027in 1 yr
Product
8062667Mar 29, 2029in 2 yr 10 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.